Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis
Fibroblast immunophenotype varied by baseline disease duration and improved model performance for identifying those with improvement on MMF. Skin biopsies may be useful for refining prognosis and guiding patient management decisions.
Authors
- Robert Spiera (ORCID: https://orcid.org/0000-0003-2911-6800)
- Hiranmayi Ravichandran (ORCID: https://orcid.org/0000-0001-8671-7667)
- Kimberly S. Lakin (ORCID: https://orcid.org/0000-0001-9343-5545)
- Deanna Jannat‐Khah (ORCID: https://orcid.org/0000-0002-1091-379X)
- Dana E. Orange (ORCID: https://orcid.org/0000-0001-9859-7199)
- Yaxia Zhang (ORCID: https://orcid.org/0000-0002-2182-4450)
- Niroshana Anandasabapathy (ORCID: https://orcid.org/0000-0002-0473-8358)
- John Spivack (ORCID: https://orcid.org/0000-0002-5347-1696)
- Jessica Gordon (ORCID: https://orcid.org/0000-0001-8068-0592)
Institutions
- Hospital for Special Surgery (US)
- Cornell University (US)
- Lander Institute (IL)
- Parker Institute for Cancer Immunotherapy (US)
- Weill Cornell Medicine (US)
- Rockefeller University (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/art.43370
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47